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404 JPGle, and Rodo OABSTRACT
Objectives: Premature babies require supplementation with calcium (Ca)
and phosphorus (P) to prevent metabolic bone disease of prematurity. To
guide mineral supplementation, 2 methods of monitoring urinary excretion
of Ca and P are used: urinary Ca or P concentration and Ca/creatinine (Crea)
or P/Crea ratios. We compare these 2 methods in regards to their agreement
on the need for mineral supplementation.
Methods: Retrospective chart review of 230 premature babies with
birth weight <1500 g, undergoing screening of urinary spot samples
from day 21 of life and fortnightly thereafter. Hypothetical cutoff
values for urine Ca or P concentration (1 mmol/L) and urine Ca/Crea ratio
(0.5 mol/mol) or P/Crea ratio (4 mol/mol) were applied to the sample results.
The agreement on whether to supplement the respective minerals based on the
results with the 2 methods was compared. Multivariate general linear models
sought to identify patient characteristics to predict discordant results.
Results: A total of 24.8% of cases did not agree on the indication for Ca
supplementation, and 8.8% for P. Total daily Ca intake was the only patient
characteristic associated with discordant results.
Conclusions: With the intention to supplement the respective mineral,
comparison of urinary mineral concentration with mineral/Crea ratio is
moderate for Ca and good for P. The results do not allow identifying
superiority of either method on the decision as to which babies require Ca
and/or P supplements.Key Words: calcium, dietary supplement, metabolic bone disease,
phosphorus, preterm infant
(JPGN 2014;58: 404–408)P remature babies miss the period of greatest mineral accretionduring the last trimester of pregnancy, when 60% and 80% of
whole-body calcium (Ca) and phosphorus (P) are transferred
actively from mother to fetus. This parallels an exponential increase
in bone formation between 24 weeks’ gestation and term (1). After
premature birth, deficiency of Ca and P caused by insufficient
nutritional supply and relative immobilization presents unfavorable
circumstances for the growth and mineralization of bone. Aggra-Treatment of Ca and P deficiencies and preventive measures
of MBDP result in the improvement of growth and bone mineral
content until 1 year of age (2,3), albeit not into adolescence or early
adulthood (4). To achieve a bone mineral accretion rate similar to
intrauterine level, individual requirements may not be met by
standardized fortified breast milk (5). Thus, the concept of monitor-
ing and individual supplementation of Ca and P arose in the early
1990s (2). Indiscriminate supplementation does not account for
variable intestinal absorption (6) and may pose risks, for example,
development of nephrocalcinosis, possibly accentuated by medi-
cations such as furosemide or steroids (7). Varying monitoring tools
are used across the different neonatal units, leading to inconsistent
practices (8).
Urinary mineral excretion in spot urine samples has been
shown to be a valuable and easy means for adjusting supplementary
intake of minerals (2,9). Two methods of measuring urinary
excretion are used: pure urinary Ca and P concentrations (milli-
moles per liter or milligrams per deciliter) or urinary calcium/
creatinine (Ca/Crea) and phosphorus/creatinine (P/Crea) ratios
(mole per mole or gram per gram). Despite the debate on the
preferred method of monitoring (10), no direct comparison of these
2 concepts has been made with regard to determining Ca and
P supplementation. This retrospective study investigates whether
the intention to supplement minerals is affected by the method
of measurement of urinary Ca and P excretion (pure Ca and
P concentration vs Ca/Crea and P/Crea ratio).
METHODS
This study was performed in the neonatology unit of the
Children’s University Hospital, Bern, Switzerland, the regional
tertiary neonatal referral center. The local institutional review board
approved the collection of the retrospective data.
Starting on day 21, urine samples are obtained from babies
with birth weight <1500 g as part of the routine metabolic screen-
ing. This is repeated every second week thereafter, until reaching a
body weight of 2500 g or discharge (whichever occurs first). To
keep the screening process noninvasive and in view of the scarce
evidence for the usefulness in detecting the need for mineral
supplementation (9,11), the local protocol does not routinely
request serum parameters for bone health (ie, serum Ca, P, alkaline
phosphatase, vitamin D) to be analyzed alongside the urinary
measurements. In this retrospective chart review, data for all babies
qualifying for screening between January 2003 and September 2006
were analyzed. Exclusion criteria were the use of diuretics at the
time of sample collection as a factor influencing calciuria (12,13),
and incomplete datasets. Even though methylxanthines (caffeine
and theophylline) also influence calciuria, indirect evidence
suggests that their calciuric effect is weaker than that of diuretics
(14); hence, patients receiving methylxanthines at the time of spot
urine sampling were included in the study. At the start of screening,duction of this article is prohibited.
were fed enterally (either fortified breast
Vevey, Switzerland] or preterm formula
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on[Beba Alprem 16% or 17%, Nestle´] and received 400 IU of vitamin
D (Cholecalciferol, Oleovit, Fresenius Kabi, Graz, Austria) as well
as 225 IU (for weight <1500 g) or 500 IU (for weight >1500 g) of
ergocalciferol through a multivitamin preparation (Oranol, Bayer,
Zurich, Switzerland) orally.
Urine samples were analyzed in an automated modular
analyzer (MODULAR Cobas P800, Roche/Hitachi Diagnostics,
Mannheim, Germany) at the central pathology service of our
university hospital. The following methods were used for analysis
(with respective coefficient of variation [CV]): colorimetric assay
with o-cresolphthalein complexon for urinary Ca (CV 0.8%),
ultraviolet test on ammonium phosphomolybdate complex for
urinary P (CV 0.7%), enzymatic method based on conversion of
Crea by creatininase, creatinase, and sarcosine oxidase for urinary
Crea (0.8%).
We applied hypothetical cutoff values to the results of urine
samples to determine the need for Ca and P supplementation. We
chose 1 mmol/L as the lower cutoff for both urinary Ca and P
concentration because this value is suggested in the only study that
used bone mineral content as an endpoint (2,10). We did not find
reference values for Ca/Crea or P/Crea for preterm babies in
the literature relating to bone mineral content (or other endpoints).
Only 1 study describes the trends of urinary mineral/Crea ratios in
P-supplemented preterm infants (15). In the absence of endpoint-
tested reference values, the 10th percentile from the percentile
curves of the aforementioned study were extrapolated for
Ca/Crea and P/Crea and used as lower cutoff values: Ca/Crea
0.5 mol/mol and P/Crea 4 mol/mol. The authors rated the
value for Ca/Crea in keeping with values reported in other studies
(9,16–18), although none of these studies have been set up to search
reference values, but merely report values found in cohorts of
similar age to our study population. For P/Crea, no references
for preterm infants could be found in either original articles or
textbooks, because percent of tubular reabsorption is ordinarily used
to assess renal excretion of P (19). Therefore, the authors agreed
upon the above value.
We produced log-log scatterplots and added lines represent-
ing the cutoff values to visualize the agreement of the 2 methods
regarding indication for mineral supplementation. Numerically, the
agreement was expressed as Cohen k. We built multivariate general
linear models to identify patient characteristics that predict discor-
dant results. The candidate predictors in the model included Ca
intake, P intake (to account for type of feeding), total daily fluid
intake, total daily protein intake, gestational age at birth, post-
menstrual age at the time of measurement, birth weight, weight at
JPGN  Volume 58, Number 4, April 2014 Mpyright 2014 by ESPGHAN and NASPGHAN. Un
time of measurement, number of days of ventilation, number
of days of noninvasive ventilation (continuous positive airway
TABLE 1. Patient characteristics and medical treatment for 230 study sub
<28 k, n¼ 67 (29%) 28-32 wk
SGA n (% of group) 11 (17) 34
Ventilation n (% of group) 55 (82) 84
Median days (range) 2 (1–54) 1
CPAP n (% of group) 65 (97) 124
Median days (range) 35 (2–86) 7.5
Oxygen n (% of group) 66 (99) 124
Median days (range) 48.5 (1–137) 10
PEN n (% of group) 57 (85) 120
Median days (range) 11 (5–49) 9
Caffeine

n (% of group) 59 (88) 64
CPAP¼ continuous positive airway pressure; PEN¼ parenteral nutrition; SG
Treatment at any time.
www.jpgn.orgpressure), days of supplemental oxygen, days of parenteral nutrition
(PEN) (the latter 4 parameters representing surrogate markers for
the degree of illness of the baby), and treatment with caffeine at the
time of urine sampling. To account for correlated data arising from
repeated measurements within patients, we fitted generalized esti-
mation equation models for the binary data using the logit link
function. Statistical analyses were performed using the software
package SAS 9.2 (SAS Institute Inc, Cary, NC).
RESULTS
Patient Characteristics
A total of 230 preterm babies (52% girls) were included in
the study. Median gestational age at birth was 29 weeksþ 1 day
(range 23þ 6 to 36þ 4) with median birth weight of 1133 g (range
420–1530). Details of the medical treatment received during the
stay in the neonatal intensive care unit are summarized in Table 1.
Generally, the patients required invasive ventilation for a short
period and reached full feeds after a similar time range (implied by
number of days on PEN). The babies included in the study under-
went a median of 2 (range 1–10) urinary screenings.
Calcium
Median urinary Ca concentration was 1.2 mmol/L (range
0.05–10.2) and median Ca/Crea ratio was 1.4 mol/mol (range
0.05–9.8). Of a total of 593 urine samples, Ca supplementation
would have been indicated in 237 (40.0%) based on the measure-
ment of urinary Ca alone. A total of 91 samples (15.5%) would have
qualified for additional Ca supplementation using the Ca/Crea ratio.
Figure 1 shows that disagreement between the 2 methods was found
in 146 (24.8%) of all samples when urinary Ca concentrations, but
not Ca/Crea, were below the cutoff values; however, there was no
case that qualified for supplementation through a Ca/Crea ratio of
<0.5 mol/mol wherein the urinary Ca concentration was above the
cutoff of 1 mmol/L at the same time. The agreement between the
2 methods was poor (k¼ 0.43, 95% confidence interval 0.36–0.49).
Median urinary Ca in the discordant range (upper left quadrant in
Fig. 1) was higher (0.68 mmol/L, range 0.23–0.99) compared with
the median urinary Ca in the lower left quadrant, where methods
agreed (0.28 mmol/L, range 0.05–0.93).
In the multivariate analysis, only Ca intake was a statistically
significant predictor of discordant results between the 2 methods.
itoring of Urinary Calcium and Phosphorus Excretion in Infantsauthorized reproduction of this article is prohibited.
This means that a high Ca intake was associated more often with a
urinary Ca concentration below the cutoff of <1 mmol/L as well as
jects by gestational age
, n¼ 132 (57%) >32 wk, n¼ 31 (14%) Total, n¼ 230
(26) 26 (84) 71 (31)
(64) 14 (45) 153 (67)
(1–26) 1 (1–5) 1 (1–54)
(94) 16 (52) 205 (53)
(1–47) 2.5 (1–9) 12 (1–86)
(94) 21 (68) 211 (92)
(1–141) 1 (1–8) 18 (1–141)
(91) 27 (87) 204 (89)
(3–47) 8 (3–42) 9 (3–49)
(48) 0 (0) 123 (53)
A¼ small-for-gestational age (birth weight <10th percentile).
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FIGURE 1. Log-log scatterplots of urinary calcium (Ca) concentration (mmol/L) versus urinary Ca/creatinine (Crea) ratio (mol/mol). Dashed lines
indicate cutoff values for supplementation: 1 mmol/l for urinary Ca concentration, 0.5 mol/mol for urinary Ca/Crea ratio.
Staub et al JPGN  Volume 58, Number 4, April 2014a Ca/Crea above the respective cutoff of 0.5 mol/mol (P¼ 0.045).
All other characteristics in the model did not predict disagreement.
Phosphorus
Median urinary P concentration was 8.35 mmol/L (range
0.5–65.5). Median P/Crea ratio was 9.9 mmol/mmol (range 0.19–
41.1). P supplementation would have been indicated in 53 of
593 urine samples (8.8%) based on urinary P concentration, and
in 105 (17.7%) based on P/Crea ratio. In 52 samples (8.8%), the
2 methods disagreed and suggested supplementation as per P/Crea
cutoff, but not as per urinary P concentration (Fig. 2). No sample
was below the cutoff for urinary P concentration and at the
same time above cutoff for P/Crea. Cohen k of 0.63 (95% confi-
dence interval 0.54–0.72) indicates good agreement between the
2 methods. As opposed to the results for Ca, none of the patients’
characteristics in the multivariate analysis predicted whether the
results of the 2 tests would disagree.
In our study population, urinary Crea concentration, urinary
Ca and P concentration, and Ca/Crea and P/Crea ratios were not age
dependent (either for gestational or chronological age) (Spearman
correlation coefficient r< 0.16).
DISCUSSION
To prevent MBDP, premature babies may need supplement-
ation of Ca and P in addition to fortified breast milk or specialized
preterm formula. In this study, we compared the intention to
supplement enteral Ca and P intake based on the 2 different
measurement methods of mineral excretion in urine: pure urinary
Ca and P concentration versus urinary Ca/Crea and P/Crea ratios.
The 2 methods only moderately agreed for Ca, but more substan-
tially agreed for P. In general, the characteristics of patients such as
weight and age (at birth or time of measurements) and surrogatepyright 2014 by ESPGHAN and NASPGHAN. Un
markers for their degree of morbidity (duration of ventilation,
continuous positive airway pressure, supplemental oxygen, PEN)
406did not show an association with the extent of concordance. The
only exception was total Ca intake, which was higher in patients
requiring additional Ca supplements according to the urinary Ca
concentration, but not the Ca/Crea ratio.
The measurement of pure Ca and P urine concentration is
based on the concept of slight surplus supply. According to this
concept, a slight surplus of serum Ca and P allow for slight urinary
excretion of Ca and P, proving indirectly sufficient serum levels,
independent of age and weight of patient (2). Previously, supple-
mentation adapted according to this concept suggested improved
bone mineralization in premature infants by densitometry, although
not in a prospective randomized design (2).
In contrast to the slight surplus supply, mineral/Crea ratios
are used on the basis that Crea and mineral concentrations are
inversely proportional to urine volume; hence, mineral/Crea ratio
corrects for volume-induced changes in concentration. Aladangady
et al (15) aimed to establish reference ranges for Ca/Crea and
P/Crea ratios in a population of premature babies already supple-
mented with P. These values are the only longitudinal description of
urinary mineral/Crea ratios during the neonatal period, but they
have not been studied against bone mineral content as a primary
endpoint.
Theoretically, mineral/Crea ratios should be superior to
pure urinary mineral concentration because in children and adults,
Ca/Crea and P/Crea are valid predictors of 24-hour Ca and
P excretion (20,21); however, the usefulness of correction for
volume-induced changes in premature infants has been contested
(10). Because most stable preterm infants receive a constant daily
fluid intake through feeding at regular intervals, no circadian
variation in urinary concentrations of minerals is to be expected
(22). Boehm et al showed that mineral/Crea ratios correlate poorly
with the daily amount of excretion (23). Additionally, Rassin et al
demonstrated an effect of dietary protein quantity and quality on
Crea concentration in the urine of premature infants, whereasauthorized reproduction of this article is prohibited.
volume of daily fluid intake did not have any influence (24). These
data suggest that the urinary Crea excretion is influenced by a
www.jpgn.org
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using it in context with the excretion of other metabolites in
premature babies.
In our study, increased total daily Ca intake was associated
with a higher likelihood of requiring Ca supplementation through
measurements of urinary Ca excretion, but not as per the Ca/Crea
ratio. Indeed, median urinary Ca in the upper left quadrant of
Figure 1 (where results disagree) is higher than in the lower left
quadrant (where results agree), raising the numerator and thereby
the total of the Ca/Crea ratio. Hence, although still requiring
supplementation with a Ca concentration <1 mmol/L, the higher
urinary Ca concentration increases the ratio sufficiently to place it
above the cutoff for Ca/Crea and therefore not warrant supplement-
ation according to this method. On the contrary, a clinical scenario in
which increased Ca intake leads to decreased urinary Crea excretion
(to decrease the ratio through a smaller denominator) is biologically
implausible, especially because parameters described in other
studies as influencing urinary Crea excretion such as weight,
postmenstrual (25) and postnatal age (26), protein quantity,
and type of nutrition (24) did not differ between the groups in
our study.
Because no previous study has investigated the present
comparison of Ca and P excretion, the question remains whether
urinary Crea and thus mineral/Crea ratio adds additional infor-
mation. Advocates for the slight surplus supply concept claim that
the exact daily amount of mineral excretion is not as important as
the concentration in spot urine samples, indicating sufficient supply
to allow excretion in urine (10). Although attempts have been made
to establish reference ranges for mineral/Crea ratios in premature
infants (15), urine Crea and consequently the ratios are likely to be
influenced by multiple factors (23,24).
The question of validity of either of the 2 screening methods
is unlikely to be answered by the existing literature because there is
no criterion standard against which the 2 methods of urine screening
could be verified. No previous study has determined cutoff values
indicate cutoff values for supplemenation: 1 mmol/L for urinary P copyright 2014 by ESPGHAN and NASPGHAN. Un
for mineral supplementation or correlated either of the 2 urine
screening methods with the presence or absence of MBDP in a
www.jpgn.orgprospective design. In the absence of an accepted criterion standard,
a meaningful accuracy study to report test sensitivity and specificity
was not possible in our study. For the same reason, it would not have
been reasonable to shift the cutoff values of the screening methods
to optimize their agreement. Such a receiver operating character-
istic analysis would require 1 of the 2 methods to be uplifted to the
criterion standard, which is not appropriate. Therefore, we had to
rely on previous studies reporting values of urinary mineral
excretion in similar cohorts, which were designed to establish
reference values or to correlate the values with bone mineral content
or other meaningful endpoints.
The lack of an accepted criterion standard for the evaluated
tests is an important limitation of our study. Future research needs to
consider an alternative to the classical diagnostic accuracy para-
digm. Clinical test validation, which measures associations between
test results and relevant clinical outcomes, could be an answer to
this difficult test evaluation situation (27). In the case of MBDP,
quantitative ultrasound (tibial speed of sound) (28) or dual energy
x-ray absorptiometry scans (29) have been used to diagnose and
follow-up bone (de)mineralization in premature infants. By demon-
strating an association between the results of either of the 2 methods
of urinary screening and the endpoints in prospective studies, cutoff
values for urinary mineral excretion could be established and
mineral supplementation adjusted accordingly.
Our analysis did not show any relation of Ca or P excretion
by either method with gestational or postnatal age. These results
contrast the findings of Aladangady et al (15) of an inverse relation
between Ca/Crea ratio and postnatal age (but not gestational age).
The consistent weight-based P supplementation of the infants in
Aladangady and colleagues’ study population may have led to a
concomitantly increased uptake of serum Ca into bone, paralleling a
decreasing Ca excretion with age. Therefore, the correlation could
reflect postnatal treatment rather than gestational maturity and
render a comparison with our study population unfeasible. Other
seemingly controversial results of studies examining associations
tration, 4 mol/mol for urinary P/Crea ratio.authorized reproduction of this article is prohibited.
between gestational or postnatal age and different measures of renal
mineral excretion (26,30) emphasize the dependence of correlations
407
Coon local practices in terms of nutrition and mineral supplement-
ation.
In conclusion, we report comparisons of urinary mineral
excretion with mineral/Crea ratios with regard to Ca and P supple-
mentation with moderate and good agreement, respectively. The
present study does not allow identification of superiority of either
method in recognizing premature babies requiring mineral supple-
ments. Further research should concentrate on prospective studies
to prove 1 of the 2 methods as a feasible monitoring tool, using total
bone mineral content as an endpoint.
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